Status:
UNKNOWN
A Real Life Evaluation of the Performance of a Large Volume Nebulizer
Lead Sponsor:
Arkansas Children's Hospital Research Institute
Collaborating Sponsors:
S&T Medical Technologies, Inc.
Conditions:
Asthma
Eligibility:
All Genders
Up to 21 years
Brief Summary
Continuous albuterol has become the standard of care for patients in status asthmaticus. We have previously performed an in-vitro study comparing 4 different brands of continuous nebulizers. We now wa...
Detailed Description
There will be no intervention to the patients. Nebulizers will be used as per current policies and procedures. They will only be marked on the outside at the water level every 2 hours for the first 6 ...
Eligibility Criteria
Inclusion
- Pediatric patients admitted to Pediatric Intensive Care Unit due to status asthmaticus, requiring continuous albuterol nebulization.
Exclusion
- Patients requiring invasive or non-invasive ventilation.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00632112
Start Date
March 1 2008
Last Update
June 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Arkansas Children's Hospital
Little Rock, Arkansas, United States, 72202